Dr. Michael A. Davies on Identifying Patients With Melanoma at Risk for Developing Brain Metastases

Michael A. Davies, MD, PhD

​Michael A. Davies, MD, PhD, discusses the importance of identifying which patients diagnosed with melanoma are at the highest risk for developing brain metastases.

Michael A. Davies, MD, PhD, associate professor, deputy chair, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the importance of identifying which patients diagnosed with melanoma are at the highest risk for developing brain metastases. He said this identification process is equally important in patients with early-stage disease as it is in patients with advanced melanoma.